Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$444M |
| 2 |
Workday
WDAY
|
+$364M |
| 3 |
AbbVie
ABBV
|
+$340M |
| 4 |
Advanced Micro Devices
AMD
|
+$312M |
| 5 |
Synopsys
SNPS
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$1.81B |
| 2 |
Apple
AAPL
|
+$947M |
| 3 |
Boston Scientific
BSX
|
+$628M |
| 4 |
Microsoft
MSFT
|
+$585M |
| 5 |
Netflix
NFLX
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Sylvamo
SLVM
$1.48B
| $261K | ﹤0.01% |
+7,832
| New | +$260K |
|
2302
BGC Group
BGC
$5.53B
| $260K | ﹤0.01% |
59,211
-60
| -0.1% | -$265 |
|
2303
Editas Medicine
EDIT
$402M
| $260K | ﹤0.01% |
+13,687
| New | +$254K |
|
2304
Noble Corp
NE
$6.75B
| $260K | ﹤0.01% |
+7,424
| New | +$209K |
|
2305
US Physical Therapy
USPH
$1.21B
| $260K | ﹤0.01% |
2,610
+1
| +0% | +$95 |
|
2306
Southside Bancshares
SBSI
$964M
| $259K | ﹤0.01% |
6,354
| – | – |
|
2307
Adaptive Biotechnologies
ADPT
$3.67B
| $258K | ﹤0.01% |
18,610
-368
| -2% | -$5.79K |
|
2308
Deluxe
DLX
$1.18B
| $258K | ﹤0.01% |
8,537
+2
| +0% | +$63 |
|
|
VRE
2309
DELISTED
Veris Residential
VRE
| $257K | ﹤0.01% |
14,785
+2
| +0% | +$35 |
|
|
TVTY
2310
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $257K | ﹤0.01% |
7,978
+2
| +0% | +$54 |
|
2311
Coursera
COUR
$1.5B
| $256K | ﹤0.01% |
11,076
-852,805
| -99% | -$17.5M |
|
|
JAMF
2312
DELISTED
Jamf
JAMF
| $255K | ﹤0.01% |
7,349
+3
| +0% | +$102 |
|
2313
Johnson Outdoors
JOUT
$493M
| $255K | ﹤0.01% |
3,293
-477
| -13% | -$40.2K |
|
2314
nCino
NCNO
$2.03B
| $254K | ﹤0.01% |
6,205
+274
| +5% | +$12.5K |
|
2315
Metropolitan Bank Holding Corp
MCB
$1.15B
| $253K | ﹤0.01% |
2,483
-163
| -6% | -$16.9K |
|
2316
Seaboard Corp
SEB
$4.26B
| $253K | ﹤0.01% |
60
| – | – |
|
|
OPI
2317
DELISTED
Office Properties Income Trust
OPI
| $252K | ﹤0.01% |
9,810
+1
| +0% | +$25 |
|
2318
Arcus Biosciences
RCUS
$3.53B
| $252K | ﹤0.01% |
7,974
-7
| -0.1% | -$235 |
|
2319
StoneX
SNEX
$9.34B
| $252K | ﹤0.01% |
17,152
+5
| +0% | +$70 |
|
|
CDMO
2320
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $252K | ﹤0.01% |
12,357
+2
| +0% | +$41 |
|
|
BRKL
2321
DELISTED
Brookline Bancorp
BRKL
| $251K | ﹤0.01% |
15,853
-2
| -0% | -$34 |
|
2322
Establishment Labs
ESTA
$2.74B
| $251K | ﹤0.01% |
3,729
| – | – |
|
2323
Agios Pharmaceuticals
AGIO
$1.87B
| $250K | ﹤0.01% |
8,584
-4,110
| -32% | -$126K |
|
2324
Apogee Enterprises
APOG
$827M
| $250K | ﹤0.01% |
5,269
-2
| -0% | -$93 |
|
2325
City Holding Co
CHCO
$2.05B
| $250K | ﹤0.01% |
3,187
-1
| -0% | -$80 |
|
Similar funds
Janus Henderson Group's Q1 2022 Portfolio in Review
As of Q1 2022, Janus Henderson Group held 2,774 positions worth $207B, down 14% from $240B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group withdrew a net $13B in Q1 2022, closing 135 positions and reducing 1,078 holdings. Its most notable exit was Xilinx Inc, an estimated $378M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Janus Henderson Group opened a new position in Tricon Residential Inc. worth $36M.
- Janus Henderson Group's largest Q1 2022 buy was Tricon Residential Inc.: 2,264,492 shares worth $36M.
- Janus Henderson Group added most to Atlassian in Q1 2022, an estimated $444M increase.
- Janus Henderson Group's biggest Q1 2022 reduction was Adobe, cutting an estimated $1.81B.
- Janus Henderson Group fully exited Xilinx Inc in Q1 2022, selling an estimated $378M.
- Janus Henderson Group's ten largest holdings make up 25% of its $207B portfolio in Q1 2022.
- Janus Henderson Group opened 230 new positions and closed 135 in Q1 2022.
- Janus Henderson Group's portfolio value fell 14% quarter-over-quarter to $207B.
Based on Janus Henderson Group's 13F filing for Q1 2022, filed 16 May 2022.